title: Quadrivalent papillomavirus vaccine in women over age 26. Cervical screening must remain a priority.
mesh_terms: D000328:Adult; D005260:Female; D005831:Genital Diseases, Female / Q000175:diagnosis / Q000517:prevention & control / Q000821:virology; D005833:Genital Neoplasms, Female / Q000175:diagnosis / Q000517:prevention & control / Q000821:virology; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D006801:Humans; D008403:Mass Screening / Q000379:methods*; D008875:Middle Aged; D030361:Papillomavirus Infections / Q000175:diagnosis / Q000517:prevention & control* / Q000821:virology; D053918:Papillomavirus Vaccines / Q000008:administration & dosage* / Q000009:adverse effects; D014626:Vaginal Smears / Q000379:methods; D055815:Young Adult
chemical_list: D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D053918:Papillomavirus Vaccines